We found 589 records for "Regulatory / compliance"

Articles

Election fever in the UK: what it means to pharma

16th April 2015

 Election fever in the UK: what it means to pharmaArticles

Campaigning for the UK General Election in May 2015 has stepped up since the dissolution of Parliament on 30 March. In the last few days the main parties – Labour,...

Read more

Electronic health records expose privacy fears

9th April 2015

 Electronic health records expose privacy fearsArticles

This is the second in a series of three articles examining the legal and ethical dilemmas faced when using new mediums and data sources for healthcare market research and data...

Read more

Reflections on eyeforpharma Barcelona: making the most of every conversation

2nd April 2015

 Reflections on eyeforpharma Barcelona: making the most of every conversationArticles

Returning from last week's eyeforpharma Barcelona event on pharmaceutical industry commercial engagement, Paul Tunnah considers the challenges it raises and some parallels with the world outside healthcare, in speaking with...

Read more

Data protection laws must not block vital healthcare research

31st March 2015

 Data protection laws must not block vital healthcare researchArticles

Sascha Marschang, Policy Manager for Health Systems, European Public Health Alliance (EPHA) argues that proposed restrictions on using health data could prevent many hugely beneficial studies being conducted in Europe.New...

Read more

News

New survival data boosts AZ's lung cancer drug

17th April 2015

 New survival data boosts AZ's lung cancer drugNews

Updated progression-free survival data for AstraZeneca's lung cancer candidate AZD9291 has put the drug firmly on course for filing in the first half of this year.Updated results from the ongoing AURA trial...

Read more

Ibrance trial stopped early on survival benefit

16th April 2015

 Ibrance trial stopped early on survival benefitNews

A phase 3 trial of Pfizer's breast cancer therapy Ibrance has been stopped early after a clear benefit on progression-free survival was seen compared to control.The PALOMA-3 study of recently-approved Ibrance (palbociclib)...

Read more

Merck wins back Breakthrough status for hepatitis combo

9th April 2015

 Merck wins back Breakthrough status for hepatitis comboNews

The FDA has awarded Breakthrough Therapy Designation to Merck's grazoprevir/elbasvir combination for hepatitis C in two specialist sub-populations.The US regulator's decision is a coup for Merck, which saw an earlier...

Read more

Clovis’ drug for advanced ovarian cancer given breakthrough status

7th April 2015

 Clovis’ drug for advanced ovarian cancer given breakthrough statusNews

Shares in the small pharma company Clovis Oncology climbed yesterday after the US FDA awarded its drug breakthrough status for treatment of advanced ovarian cancer.Rucaparib is in the PARP inhibitor...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Controlled Release

20th April 2015 - 21st April 2015

Controlled Release

Following on from our previous events, SMi’s is proud to present their Controlled Release Conference taking place on 20th & 21st April 2015. This two day forum is set to...

Read more

Adaptive Designs in Clinical Trials

20th April 2015 - 21st April 2015

Adaptive Designs in Clinical Trials

Now in its 7th year, SMi is pleased to announce their 2015 agenda for Adaptive Designs in Clinical Trials taking place on 20th & 21st April 2015. The conference continues...

Read more

2nd Annual Medical Device Supplier Quality Assurance Conference

20th April 2015 - 21st April 2015

2nd Annual Medical Device Supplier Quality Assurance Conference

Examine the most up-to-date information in implementing quality agreements, as well as effective communication strategies and constructive supplier development initiatives while meeting FDA expectations for supplier oversight....

Read more

Clinical Evaluations and Investigations for Medical Devices

22nd April 2015 - 23rd April 2015

Clinical Evaluations and Investigations for Medical Devices

Join us in April for essential regulatory updates and success strategies for executing clinical evaluations and investigations in a changing regulatory landscape. Key features for 2015: • Discover industry best practice for...

Read more

Press Releases

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

15th April 2015

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

  The eagerly awaited second edition of Arthur G. Cook's Forecasting for the Pharmaceutical Industry is now available from Gower.     Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as...

Read more

Veeva Systems Introduces Veeva OpenKey

24th March 2015

Veeva Systems Introduces Veeva OpenKey

  Veeva Systems has launched Veeva OpenKey, a new type of customer data solution for the life sciences industry.  As the life sciences business continues to diversify across borders and new channels,...

Read more

Adelphi Research UK Refreshes Corporate Brand & Positioning

4th March 2015

Adelphi Research UK Refreshes Corporate Brand & Positioning

    Adelphi Research UK has a strong heritage of providing robust market research in the healthcare sector. Established since 2000, they have extensive expertise in pharma, and also span OTC and...

Read more

OPEN Health introduces its market access division OPEN Access Consulting

8th December 2014

OPEN Health introduces its market access division OPEN Access Consulting

Marlow, 4 December 2014: OPEN Health announced the launch of its dedicated market access division, OPEN Access Consulting. OPEN Access Consulting brings together existing market access expertise from Succinct Medical Communications...

Read more